Literature DB >> 26033546

Corpus callosum involvement and postoperative outcomes of patients with gliomas.

Ko-Ting Chen1, Tai-Wei Erich Wu1, Chi-Cheng Chuang1,2, Yung-Hsin Hsu1,2, Peng-Wei Hsu1,2, Yin-Cheng Huang1,2, Tzu-Kang Lin1,2, Chen-Nen Chang1,2, Shih-Tseng Lee1,2, Chieh-Tsai Wu1,2, Chen-Kan Tseng3, Chun-Chieh Wang3, Ping-Ching Pai3, Kuo-Chen Wei1,2, Pin-Yuan Chen4,5.   

Abstract

Corpus callosum involvement is associated with poorer survival in high grade glioma (HGG), but the prognostic value in low grade glioma (LGG) is unclear. To determine the prognostic impact of corpus callosum involvement on progression free survival (PFS) and overall survival (OS) in HGG and LGG, the records of 233 glioma patients treated from 2008 to 2011 were retrospectively reviewed. Preoperative magnetic resonance (MR) images were used to identify corpus callosum involvement. Age, sex, preoperative Karnofsky performance scale, postoperative Eastern Cooperative Oncology Group (ECOG) score and extent of resection (EOR) were evaluated with respect to PFS and OS. The incidence of corpus callosum involvement was similar among HGG (14 %) and LGG (14.5 %). Univariate analysis revealed that PFS and OS were significantly shorter in both WHO grade II and grade IV glioma with corpus callosum involvement (both, p < 0.05). Multivariate analysis showed that grade II glioma with corpus callosum involvement have shorter PFS (p = 0.03), while EOR, instead of corpus callosum involvement (p = 0.16), was an independent factor associated with PFS in grade IV glioma (p < 0.05). Corpus callosum involvement was no longer significantly associated with OS after adjusting age, gender, EOR, preoperative and postoperative performance status (p = 0.16, 0.17 and 0.56 in grade II, III and IV gliomas, respectively). Corpus callosum involvement happened in both LGG and HGG, and is associated with lower EOR and higher postoperative ECOG score both in LGG and HGG. Corpus callosum involvement tends to be an independent prognostic factor for PFS in LGG, but not for OS in LGG or in HGG.

Entities:  

Keywords:  Corpus callosum; Extent of resection (EOR); Glioma; Overall survival (OS); Progression free survival (PFS)

Mesh:

Year:  2015        PMID: 26033546     DOI: 10.1007/s11060-015-1823-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  23 in total

1.  Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

Authors:  Patrick Y Wen; David R Macdonald; David A Reardon; Timothy F Cloughesy; A Gregory Sorensen; Evanthia Galanis; John Degroot; Wolfgang Wick; Mark R Gilbert; Andrew B Lassman; Christina Tsien; Tom Mikkelsen; Eric T Wong; Marc C Chamberlain; Roger Stupp; Kathleen R Lamborn; Michael A Vogelbaum; Martin J van den Bent; Susan M Chang
Journal:  J Clin Oncol       Date:  2010-03-15       Impact factor: 44.544

2.  Grade II oligodendroglioma localized to the corpus callosum.

Authors:  Edward A Monaco; Henry B Armah; Marina N Nikiforova; Ronald L Hamilton; Johnathan A Engh
Journal:  Brain Tumor Pathol       Date:  2011-07-22       Impact factor: 3.298

Review 3.  An MRI review of acquired corpus callosum lesions.

Authors:  Dimitri Renard; Giovanni Castelnovo; Chantal Campello; Stephane Bouly; Anne Le Floch; Eric Thouvenot; Anne Waconge; Guillaume Taieb
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-02-21       Impact factor: 10.154

4.  Evaluating the prognostic factors effective on the outcome of patients with glioblastoma multiformis: does maximal resection of the tumor lengthen the median survival?

Authors:  Faramarz Allahdini; Abbass Amirjamshidi; Mohammad Reza-Zarei; Morteza Abdollahi
Journal:  World Neurosurg       Date:  2009-10-21       Impact factor: 2.104

5.  A retrospective survey of patients with malignant gliomas treated in the neuro-oncological care system under the Universal National Health Insurance program in Taiwan.

Authors:  Yin-Cheng Huang; Kuo-Chen Wei; Chin-Hong Chang; Jen-Tsung Yang; Jih-Tsun Ho; Chiung-Chyi Shen; Chain-Fa Su; Der-Yang Cho; Hsin-I Ma; Jia-Wei Lin; E-Jian Lee; Jionn-Jong Wu; Ming-Dar Tsai; Cheng-Kuei Chang; Shen-Long Howng; Chen-Nen Chang
Journal:  J Clin Neurosci       Date:  2011-04-19       Impact factor: 1.961

Review 6.  Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas.

Authors:  M J van den Bent; J S Wefel; D Schiff; M J B Taphoorn; K Jaeckle; L Junck; T Armstrong; A Choucair; A D Waldman; T Gorlia; M Chamberlain; B G Baumert; M A Vogelbaum; D R Macdonald; D A Reardon; P Y Wen; S M Chang; A H Jacobs
Journal:  Lancet Oncol       Date:  2011-04-05       Impact factor: 41.316

7.  Butterfly glioma of the corpus callosum.

Authors:  Amit Agrawal
Journal:  J Cancer Res Ther       Date:  2009 Jan-Mar       Impact factor: 1.805

8.  A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme.

Authors:  Kaisorn Chaichana; Scott Parker; Alessandro Olivi; Alfredo Quiñones-Hinojosa
Journal:  J Neurosurg       Date:  2010-05       Impact factor: 5.115

9.  Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas.

Authors:  Justin S Smith; Edward F Chang; Kathleen R Lamborn; Susan M Chang; Michael D Prados; Soonmee Cha; Tarik Tihan; Scott Vandenberg; Michael W McDermott; Mitchel S Berger
Journal:  J Clin Oncol       Date:  2008-03-10       Impact factor: 44.544

Review 10.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

View more
  5 in total

Review 1.  Gliomas Infiltrating the Corpus Callosum: A Systematic Review of the Literature.

Authors:  Paolo Palmisciano; Gianluca Ferini; Gina Watanabe; Christian Ogasawara; Emal Lesha; Othman Bin-Alamer; Giuseppe E Umana; Kenny Yu; Aaron A Cohen-Gadol; Tarek Y El Ahmadieh; Ali S Haider
Journal:  Cancers (Basel)       Date:  2022-05-19       Impact factor: 6.575

2.  Predicting surgical outcome in patients with glioblastoma multiforme using pre-operative magnetic resonance imaging: development and preliminary validation of a grading system.

Authors:  Hani J Marcus; Sophie Williams; Archie Hughes-Hallett; Sophie J Camp; Dipankar Nandi; Lewis Thorne
Journal:  Neurosurg Rev       Date:  2017-02-15       Impact factor: 3.042

Review 3.  Physiological Imaging Methods for Evaluating Response to Immunotherapies in Glioblastomas.

Authors:  Sanjeev Chawla; Vanessa Shehu; Pradeep K Gupta; Kavindra Nath; Harish Poptani
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

4.  Combined use of multimodal techniques for the resection of glioblastoma involving corpus callosum.

Authors:  Meng Cui; Hewen Chen; Guochen Sun; Jialin Liu; Meng Zhang; Hepu Lin; Caihong Sun; Xiaodong Ma
Journal:  Acta Neurochir (Wien)       Date:  2021-10-12       Impact factor: 2.816

5.  Benefits of glioma resection in the corpus callosum.

Authors:  Marie-Therese Forster; Marion Behrens; Irina Lortz; Nadine Conradi; Christian Senft; Martin Voss; Maximilian Rauch; Volker Seifert
Journal:  Sci Rep       Date:  2020-10-06       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.